GSK Investigational Site

New Albany, Indiana 47510

0 studies enrolling now · 10 studies all time

What they study most

Atrophy, Geographic, Chemotherapy-Induced Nausea and Vomiting, Dermatitis, Atopic, Influenza, Lung Cancer, Non-Small Cell, Measles, Measles-Mumps-Rubella Vaccine, Mumps, Nausea and Vomiting, Chemotherapy-Induced, Pulmonary Disease, Chronic Obstructive, Rubella, Sepsis

Studies at this site

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — Completed
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age — Completed
• Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children — Completed
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration — Completed
• A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy — Completed